143 related articles for article (PubMed ID: 21913652)
21. Transcripts of neurokinin B and neurokinin 3 receptor in superovulated rat ovaries and increased number of corpora lutea as a non-specific effect of intraperitoneal agonist application.
Löffler S; Schulz A; Brylla E; Nieber K; Spanel-Borowski K
Regul Pept; 2004 Oct; 122(2):131-7. PubMed ID: 15380930
[TBL] [Abstract][Full Text] [Related]
22. A regulatory role for neurokinin B in placental physiology and pre-eclampsia.
Page NM; Woods RJ; Lowry PJ
Regul Pept; 2001 Apr; 98(3):97-104. PubMed ID: 11231038
[TBL] [Abstract][Full Text] [Related]
23. Extracellular domains of the neurokinin-1 receptor: structural characterization and interactions with substance P.
Ulfers AL; Piserchio A; Mierke DF
Biopolymers; 2002; 66(5):339-49. PubMed ID: 12539262
[TBL] [Abstract][Full Text] [Related]
24. Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists.
Lavecchia A; Cosconati S; Novellino E
J Med Chem; 2005 Apr; 48(7):2480-92. PubMed ID: 15801838
[TBL] [Abstract][Full Text] [Related]
25. Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages.
Brylla E; Aust G; Geyer M; Uckermann O; Löffler S; Spanel-Borowski K
Regul Pept; 2005 Feb; 125(1-3):125-33. PubMed ID: 15582723
[TBL] [Abstract][Full Text] [Related]
26. Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 - 2010).
Malherbe P; Ballard TM; Ratni H
Expert Opin Ther Pat; 2011 May; 21(5):637-55. PubMed ID: 21417773
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
Misu R; Noguchi T; Ohno H; Oishi S; Fujii N
Bioorg Med Chem; 2013 Apr; 21(8):2413-2417. PubMed ID: 23473945
[TBL] [Abstract][Full Text] [Related]
28. Toward the active conformations of rhodopsin and the beta2-adrenergic receptor.
Gouldson PR; Kidley NJ; Bywater RP; Psaroudakis G; Brooks HD; Diaz C; Shire D; Reynolds CA
Proteins; 2004 Jul; 56(1):67-84. PubMed ID: 15162487
[TBL] [Abstract][Full Text] [Related]
29. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
30. Distribution and pharmacological characterization of primate NK-1 and NK-3 tachykinin receptors in the central nervous system of the rhesus monkey.
Nagano M; Saitow F; Haneda E; Konishi S; Hayashi M; Suzuki H
Br J Pharmacol; 2006 Feb; 147(3):316-23. PubMed ID: 16331282
[TBL] [Abstract][Full Text] [Related]
31. Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.
Ha SN; Hey PJ; Ransom RW; Harrell CM; Murphy KL; Chang R; Chen TB; Su DS; Markowitz MK; Bock MG; Freidinger RM; Hess FJ
Biochem Biophys Res Commun; 2005 May; 331(1):159-66. PubMed ID: 15845373
[TBL] [Abstract][Full Text] [Related]
32. The steric trigger in rhodopsin activation.
Shieh T; Han M; Sakmar TP; Smith SO
J Mol Biol; 1997 Jun; 269(3):373-84. PubMed ID: 9199406
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of activation of peripheral and spinal tachykinin neurokinin(3) receptors on the micturition reflex in rats.
Kamo I; Chancellor MB; de Groat WC; Yoshimura N
J Urol; 2005 Aug; 174(2):776-81. PubMed ID: 16006975
[TBL] [Abstract][Full Text] [Related]
34. Distribution and pharmacological characterization of primate NK-2 tachykinin receptor in the central nervous system of the rhesus monkey.
Nagano M; Oishi T; Suzuki H
Neurosci Lett; 2011 Sep; 503(1):23-6. PubMed ID: 21855604
[TBL] [Abstract][Full Text] [Related]
35. Membrane-induced secondary structures of neuropeptides: a comparison of the solution conformations adopted by agonists and antagonists of the mammalian tachykinin NK1 receptor.
Whitehead TL; McNair SD; Hadden CE; Young JK; Hicks RP
J Med Chem; 1998 Apr; 41(9):1497-506. PubMed ID: 9554882
[TBL] [Abstract][Full Text] [Related]
36. Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms.
Grant AD; Akhtar R; Gerard NP; Brain SD
J Physiol; 2002 Sep; 543(Pt 3):1007-14. PubMed ID: 12231654
[TBL] [Abstract][Full Text] [Related]
37. Identification of structural motifs critical for epstein-barr virus-induced molecule 2 function and homology modeling of the ligand docking site.
Zhang L; Shih AY; Yang XV; Kuei C; Wu J; Deng X; Mani NS; Mirzadegan T; Sun S; Lovenberg TW; Liu C
Mol Pharmacol; 2012 Dec; 82(6):1094-103. PubMed ID: 22930711
[TBL] [Abstract][Full Text] [Related]
38. Homology model-assisted elucidation of binding sites in GPCRs.
Levit A; Barak D; Behrens M; Meyerhof W; Niv MY
Methods Mol Biol; 2012; 914():179-205. PubMed ID: 22976029
[TBL] [Abstract][Full Text] [Related]
39. Homology modelling and binding site mapping of the human histamine H1 receptor.
Kiss R; Kovári Z; Keseru GM
Eur J Med Chem; 2004 Nov; 39(11):959-67. PubMed ID: 15501545
[TBL] [Abstract][Full Text] [Related]
40. Comparative modeling of human kappa opioid receptor and docking analysis with the peptide YFa.
Patra MC; Kumar K; Pasha S; Chopra M
J Mol Graph Model; 2012 Mar; 33():44-51. PubMed ID: 22172315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
